🇺🇸 FDA
Pipeline program

anti-thymocyte globulin

199/14983

Unknown small_molecule active

Quick answer

anti-thymocyte globulin for Graft Versus Host Disease is a Unknown program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Graft Versus Host Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials